C-176 is primarily utilized in research and development within the field of immunology and inflammation studies. It is known for its role as a selective inhibitor of the NLRP3 inflammasome, a protein complex involved in the regulation of inflammatory responses. By targeting NLRP3, C-176 helps researchers investigate mechanisms underlying inflammatory diseases such as gout, type 2 diabetes, and Alzheimer's disease. Its application extends to preclinical studies aimed at understanding the pathways of innate immunity and developing potential therapeutic strategies for conditions driven by excessive inflammation. Additionally, C-176 is used in experimental models to evaluate its efficacy in reducing inflammation-related tissue damage, providing insights into its potential as a drug candidate.